" class="no-js "lang="en-US"> Neumora - Medtech Alert
Friday, August 01, 2025
Neumora | Pharmtech Focus

Neumora

About Neumora

Neumora

Brain diseases are not “one-size-fits-all” – but the industry currently treats them that way. At Neumora, our mission is to transform the treatment and patient outcomes for brain diseases –
with precision.

Our proprietary toolbox of state-of-the-art neural network technologies is built to integrate multiple types of data across genomics, imaging, electroencephalogram (EEG), digital and clinical domains to create Data Biopsy Signatures™ that map the underlying disease mechanisms to Precision Phenotypes™ that identify distinct patient subtypes. Through this approach, we have the ability to develop and match the right therapeutic to the right patient populations for more targeted treatments.

Together, we are committed to creating a new era in modern precision medicine. Brain disease doesn’t wait. And neither will we.

Related Story

Amgen and Neumora Therapeutics Announce Strategic R&D Collaboration to Accelerate Novel Precision Therapies for Brain Diseases

October 7 2021

Amgen (NASDAQ: AMGN) and Neumora Therapeutics, Inc. (Neumora), a clinical-stage biopharmaceutical company pioneering precision medicines for […]